Why did Veeva Systems (VEEV) stock move recently?

On 8/27/2026, Veeva Systems moved +16.9% — Veeva Systems reported fiscal Q2 revenue up 18% year on year to $928mn and adjusted EPS of $2.35, both above consensus, and raised its full-year FY27 revenue and EPS outlook. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Veeva Systems (VEEV) overvalued or fairly valued?

MarketChacha shows Veeva Systems's valuation in context — a trailing P/E of about 49.7, a forward P/E of about 27.8, a price-to-book of about 6.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Veeva Systems's reported profit turn into cash?

Over 4 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.59×) from reported figures — education, not a rating.

What is Veeva Systems's revenue?

Veeva Systems reported revenue of $3.2B for FY2026, with net profit of $908.9M, per official filings.

What is the share price of Veeva Systems (VEEV)?

Veeva Systems last traded at $275.09 (-3.3% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Veeva Systems

VEEV · NASDAQ · Healthcare · United States

Snapshot

TickerVEEV

ExchangeNASDAQ

SectorHealthcare

IndustryHealth Information Services

CountryUnited States

Employees7,928

HeadquartersPleasanton, United States

Websitewww.veeva.com

Filings tracked14

About Veeva Systems

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Who owns it

Insiders8.6%
Institutions91.4%
Public & other0.0%

1,547 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.7.94%
Vanguard Capital Management LLC5.99%
Vanguard Portfolio Management LLC4.58%
State Street Corporation4.14%
Principal Financial Group, Inc.3.08%
Alliancebernstein L.P.3.03%
Geode Capital Management, LLC2.78%
Linonia Partnership LP2.72%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.59×

Over 4 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend22.6% → 28.4%

Margin has expanded by about 5.8 points — the business is getting more profitable.

Growth qualityrev 14% · PAT 23%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $944.1M · EPS 2.31

Est. earnings growth +12.0%

Next fiscal year

Rev $4.1B · EPS 10.24

Est. earnings growth +10.9%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2026)

$3.2B

Net margin

28.4%

ROE

12.6%

Revenue CAGR (3y)

+14.0%

Profit CAGR (3y)

+23.1%

EPS (FY2026)

5.44

Net profit (FY2026)

$908.9M

Ask MarketChacha about VEEV

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Aug 27, 2026
Veeva Systems reported fiscal Q2 revenue up 18% year on year to $928mn and adjusted EPS of $2.35, both above consensus, and raised its full-year FY27 revenue and EPS outlook.
source 1 ↗· confidence: high

Daily moves with the verified reason behind them. Education only — not investment advice.

On MarketChacha

Posts about VEEV

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2026	$3.2B	$908.9M	5.44	28.4%	12.6%
FY2025	$2.7B	$714.1M	4.32	26.0%	12.2%
FY2024	$2.4B	$525.7M	3.22	22.2%	11.3%
FY2023	$2.2B	$487.7M	3.00	22.6%	13.1%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$882.9M	$260.9M	1.57	29.6%
2025Q4	$811.2M	$236.2M	1.40	29.1%
2025Q3	$789.1M	$200.3M	1.19	25.4%
2025Q2	$759.0M	$228.2M	1.37	30.1%
2024Q4	$699.2M	$185.8M	1.13	26.6%
2024Q3	$676.2M	$171.0M	1.04	25.3%
2024Q2	$650.3M	$161.7M	0.98	24.9%
2023Q4	$616.5M	$135.2M	0.83	21.9%
2023Q3	$590.2M	$111.6M	0.68	18.9%
2023Q2	$526.3M	$131.5M	0.81	25.0%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Shareholder vote results, Exhibits
SEC6/18/2026material
10-Q filing
SEC6/5/2026
8-K — Results of operations, Exhibits
SEC6/3/2026material
8-K — Executive/director change, Exhibits
SEC4/20/2026material
10-K filing
SEC3/20/2026
8-K — Results of operations, Exhibits
SEC3/4/2026material
8-K — Other events, Exhibits
SEC1/5/2026material

2025

8-K — Executive/director change, Exhibits
SEC12/11/2025material
10-Q filing
SEC11/21/2025
8-K — Results of operations, Exhibits
SEC11/20/2025material
8-K — Executive/director change, Exhibits
SEC11/18/2025material
10-Q filing
SEC8/29/2025
8-K — Results of operations, Exhibits
SEC8/27/2025material
8-K — Reg FD disclosure, Exhibits
SEC8/18/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.